Fieldpoint Private Securities’s Neurocrine Biosciences NBIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$102K Sell
2022
Q1
$102K Buy
2021
Q4
$88K Sell
2021
Q3
$101K Hold
2021
Q2
$92K Buy
2021
Q1
$101K Sell
2020
Q4
$128K Buy